The nation faces a clear vulnerability: China’s reach into U.S. medical technology and data systems is no longer theoretical, and people across health care and government are raising alarms about backdoors, compromised devices, and supply chains that hand sensitive information to Beijing.
Former Secretary of Homeland Security Chad Wolf is leading that alarm, arguing this is a national security problem that hits patients and hospitals first. State and federal officials are coordinating to tighten defenses after warnings about foreign access to medical equipment. The debate now centers on how aggressively to purge compromised devices and close any pathways that allow data to leave American systems.
Last week, several state attorneys general teamed with the Federal Communications Commission to sign a memorandum aimed at strengthening protections against foreign infiltration of communications gear. That move underscores how broad the worry has become, extending beyond phones and routers into hospitals and clinics. The message is clear: trusted networks and life-saving instruments cannot be left exposed to adversaries.
Conservative groups have also jumped in, launching campaigns to spotlight the risk of Chinese-made medical technology inside U.S. health facilities. The new Protecting America Initiative frames the issue as one of patient safety and national security. Their aim is to build public pressure for quick policy and procurement changes to keep Beijing out of hospital systems.
Federal agencies have not been silent. Earlier this year the Food and Drug Administration and the Cybersecurity and Infrastructure Security Agency warned about a “backdoor” in a widely used patient monitoring device. CISA’s analysis found the device could download remote files and transmit them to an IP address tied to a Chinese university, an institution that by law must cooperate with national intelligence requests. That single technical finding has broad implications for how we certify and vet medical technology.
“Americans rely on their doctors who take an oath to keep us safe, and first, do no harm. But when critical medical devices are made by Chinese companies, that puts our safety at risk. Chinese medical devices open the door for the CCP to access sensitive health data. President Trump and his administration always put America First and will safeguard our patients and our privacy from Beijing’s infiltration,” PAI Senior Advisor Chad Wolf told Fox News Digital. “It’s time to remove Chinese medical devices from U.S. hospitals and close the data backdoor, because patient privacy and national security are non‑negotiable.”
On the enforcement front, a Republican state attorney general in Florida has subpoenaed Chinese manufacturers linked to the compromised monitors, accusing them of selling devices with exploitable access points. The legal action accuses vendors and distributors of representing their products as meeting regulatory standards when they allegedly did not. That lawsuit signals states are ready to use the courts to protect patients and force transparency in medical supply chains.
There are broader concerns about approval and oversight, too, including whether some devices cleared for use actually meet U.S. safety and cybersecurity expectations. Regulators are being pushed to tighten rules on provenance and to require stricter attestations about firmware, remote update mechanisms, and data flows. Hospitals are now asking whether cheaper foreign parts and final assembly are worth the potential risk to privacy and public health.
The Foundation for Defense of Democracies laid out the supply-chain challenge in detail, noting the role of Beijing’s industrial policy and global manufacturing shifts. “China’s growing role within the U.S. medical device supply chains is largely due to the combination of Beijing’s industrial policy and the shifting landscape of American healthcare,” the Foundation for Defense of Democracies (FDD) wrote in an October report. The report cites a National Institutes of Health estimate that in 2019 roughly 9.2 percent of U.S.-imported pharmaceuticals and medical equipment came from China, a figure the NIH warned “likely understates” American reliance on China for medical products.
“This understatement is in part due to the complex nature of medical supply chains — China is both a supplier of raw materials used in medical products and the final point of assembly for goods bound for the United States, obscuring its reach into the American medical system. This percentage also does not account for the value-add or criticality of these goods, particularly those related to biodefense and managing long-term acute health issues,” the report continues. FDD goes further, saying China has “exploited” the United State’s “reliance” by selling technology with intentional vulnerabilities and leaving doctors effectively “unwittingly and unwillingly” playing “Russian roulette with patient treatment plans.”
Graduate Student, wife, engaged political and legal writer.